aPatient Terms and Conditions: The Kadmon
ASSIST Commercial Co-pay Savings
Program provides co-pay/coinsurance
support for out-of-pocket costs on
REZUROCKTM (belumosudil) tablets prescriptions, up to $25,000 per calendar year, limit one 30-day supply per 30 days. This program is not health insurance. This program is for commercially or privately insured patients only; uninsured or cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state- or federally funded programs, including, but not limited to, Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, TriCare, private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. The co-pay program may not be combined with any other rebate, coupon or offer. Kadmon Pharmaceuticals, LLC, reserves the right to rescind, revoke or amend this offer without further notice. Card is valid through December 31 of the year of activation. On January 1 of the following year, the card automatically resets and is subject to annual limits if the prescription benefit remains the same.
Patients who are not eligible for
any affordability programs
through Kadmon ASSIST (eg,
Medicare, Medicaid, federal or
state program) may be referred
to an independent charitable
foundation for assistance.
All patients are eligible for
benefits investigation and
verification services, as well as
For eligible patients with commercial